Public Profile

JSC Valenta Pharm

JSC Valenta Pharm, a prominent player in the pharmaceutical industry, is headquartered in Russia and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development and production of high-quality generic medications and innovative pharmaceutical solutions. Valenta Pharm's core offerings include a diverse range of therapeutic products, particularly in the fields of oncology, cardiology, and neurology, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. With a focus on research and development, JSC Valenta Pharm continues to drive advancements in healthcare, making it a trusted name among healthcare professionals and patients alike.

DitchCarbon Score

How does JSC Valenta Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

JSC Valenta Pharm's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

JSC Valenta Pharm's reported carbon emissions

JSC Valenta Pharm, headquartered in Russia, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many organisations in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprint across various scopes of emissions. As JSC Valenta Pharm continues to navigate the evolving landscape of environmental responsibility, it may consider establishing measurable climate commitments in line with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. JSC Valenta Pharm's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for JSC Valenta Pharm is in RU, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

JSC Valenta Pharm is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Uem Sunrise

MY
Real estate services (70)
Updated 3 days ago

IJM Land Bhd

MY
Real estate services (70)
Updated 3 months ago
DitchCarbon Score

Ioi Properties Berhad

MY
Real estate services (70)
Updated 3 months ago
DitchCarbon Score

S P Setia Berhad

MY
Real estate services (70)
Updated 4 days ago

Tropicana Corporation Berhad

MY
Real estate services (70)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers